InVivo Therapeutics Holdings, a biomaterials company, has appointed Tamara Joseph as general counsel and chief compliance officer, effective March 24.

Joseph comes to InVivo with extensive leadership experience in the biotechnology and pharmaceutical industries, having held numerous senior positions in the United States and Europe over the past 16 years. Previously, she served as general counsel of Cubist Pharmaceuticals, where she was responsible for the law, compliance, risk management, and government affairs departments.

Prior to Cubist, other positions she has held include general counsel of Mayne Pharma; general counsel at Transkaryotic Therapies; and vice president of international legal for Biogen Idec. She began her legal career as a litigator with Fried, Frank, Harris, Shriver & Jacobson, and later at Morrison & Foerster.